INGR — Ingredion Incorporated

Ingredion Inc. Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Net Sales: $1.8 billion, down 2% year-over-year.
• Gross Profit: Decreased by 4%, with a gross margin of 24.5%.
• Operating Income: Reported at $220 million; adjusted operating income at $228 million.
• Full Year Net Sales: $7.2 billion, down 3% from the previous year.
• Full Year Gross Profit: Increased by 2%, with a gross margin of 25.3%.
• Adjusted EPS: Increased by 4.5% year-over-year; projected for 2026 in the range of $11 to $11.80.

2. Strategic Updates and Business Highlights

• Texture and Healthful Solutions: Achieved 4% volume growth for the seventh consecutive quarter, driven by clean label ingredients. Operating income grew by 16% year-over-year.
• Food and Industrial Ingredients LatAm: Despite challenges, operating income reached a record of $493 million, with a margin of 21.1%. Mexico showed resilience with a 3% growth in food volumes.
• Operational Improvements: Completed modernization projects at the Indianapolis facility, expected to enhance efficiency and capacity.
• Cost Savings: Delivered $59 million in Cost2Compete run rate savings, exceeding the target of $50 million.

3. Forward Guidance and Outlook

• 2026 Guidance: Anticipates low single-digit to mid-single-digit growth in net sales, with adjusted operating income also expected to rise low single digits.
• Segment Outlook:
  • Texture and Healthful Solutions: Expected to grow low single digits to mid-single digits in net sales and operating income.
  • Food and Industrial Ingredients LatAm: Projected to be flat to low single-digit growth.
  • Food and Industrial Ingredients U.S./Canada: Expected to be flat year-over-year, with continued challenges from the Argo facility.
• Cash Flow: Expected cash from operations between $820 million to $940 million, with capital expenditures projected at $400 million to $440 million.

4. Bad News, Challenges, or Points of Concern

• Operational Challenges: The Argo facility faced ongoing production issues, resulting in a $40 million impact on operating income for 2025. Q4 saw a $16 million loss attributed to these challenges.
• Volume Declines: The U.S./Canada segment experienced a 7% decrease in net sales volume, primarily due to Argo's operational difficulties and a soft beverage sweetener market.
• Inflationary Pressures: Anticipated manufacturing cost inflation not fully offset by pricing, affecting gross margins.
• Regulatory Risks: New sugar taxes in Mexico may impact beverage volumes, with potential short-term declines expected.

5. Notable Q&A Insights

• Argo Facility Impact: Approximately two-thirds of the Q4 volume decline was attributed to Argo's issues, with expectations for recovery in the second half of 2026.
• Texture and Healthful Solutions Pricing: Contracting for 2026 showed slight pricing declines, with expectations that manufacturing cost inflation may not be fully covered.
• LatAm Business Dynamics: Brewing adjunct volumes declined significantly, but food and beverage volumes showed positive growth in Mexico.
• GLP-1 Impact: The rise of GLP-1 medications is positively impacting the protein fortification business, with expectations for continued revenue growth.

Overall, Ingredion demonstrated resilience in a challenging environment, with strategic initiatives aimed at driving growth despite operational setbacks and market pressures.